李建斌;刘新彦;李志强;王丽坤;路继成;李晓丽;
LI Jianbin;LIU Xinyan;LI Zhiqiang;WANG Likun;LU Jicheng;LI Xiaoli;Department of Otorhinolaryngology,Central Hospital of China National Petroleum Corporation;Department of Otorhinolaryngology-Head and Neck Surgery,the Second Affiliated Hospital,Hebei North University;Department of Pathology,the Second Affiliated Hospital of Hebei North University;Department of Clinical Laboratory,Xuanhua District People's Hospital;

• 1:中国石油天然气集团公司中心医院耳鼻咽喉科
• 2:河北北方学院附属第二医院耳鼻咽喉头颈外科
• 3:河北北方学院附属第二医院病理科
• 4:宣化区人民医院检验科

摘要(Abstract)：

目的:探讨鼻咽癌组织中脑恶性肿瘤缺失基因1(DMBT1)的表达与临床病理的关系。方法:选取48例鼻咽癌患者的鼻咽癌组织、48例正常鼻咽部组织,采用免疫组织化学方法及实时定量PCR方法检测组织中DMBT1蛋白及mRNA的表达水平,分析DMBT1蛋白表达与鼻咽癌患者性别、年龄,鼻咽癌的临床分期、分化程度及颈部淋巴转移的关系。结果:DMBT1蛋白在鼻咽癌组织中的表达阳性率(31.25%)低于正常鼻咽部组织(79.17%),差异有统计学意义(P<0.01);鼻咽癌组织中DMBT1 mRNA表达明显低于正常鼻咽部组织,差异有统计学意义(P<0.05);DMBT1蛋白表达与鼻咽癌的临床分期、细胞分化程度及有无颈淋巴转移有关(P<0.05),与患者的年龄和性别无关(P>0.05)。结论:DMBT1在鼻咽癌组织中表达水平降低,与鼻咽癌的浸润转移及发生发展有关。
Objective: To investigate the relationship between the expression level of DMBT1 in human nasopharyngeal carcinoma tissues and clinicopathological characteristics. Methods: The immunohistochemical method and RT-PCR were used to detect the DMBT1 expressions in 48 cases of nasopharyngeal carcinoma tissues and 48 cases of normal nasopharyngeal tissues. The relationship between DMBT1 protein expression and gender,age,clinical stage,differentiation degree and cervical lymph node metastasis of nasopharyngeal carcinoma was analyzed. Results: The positive DMBT1 expression rate was 31. 25%( 15/48) in nasopharyngeal carcinoma tissue while that of normal nasopharynx tissue was 79. 17%( 38/48),the difference was statistically significant( P < 0. 01); RT-PCR results showed that the expression of DMBT1 mRNA in nasopharyngeal carcinoma tissues was significantly lower than that of normal nasopharynx tissues( P < 0. 05). The protein expression of DMBT1 had no correlation with the age and gender of the patients( P > 0. 05),but was related with the tumor cell differentiation,cervical lymphatic metastasis,and clinical stages( P < 0. 05). Conclusions: The expression level of DMBT1 in nasopharyngeal carcinoma tissues decreased that was related to infiltration metastasis and development of nasopharyngeal carcinoma.

关键词(KeyWords)： 鼻咽肿瘤;免疫组织化学;淋巴转移;细胞分化;肿瘤分期;实时定量PCR;脑恶性肿瘤缺失基因1
nasopharyngeal tumor;immunohistochemistry;lymphatic metastasis;cell differentiation;tumor stage;real time quantitative PCR;brain malignant tumor deletion gene 1

Abstract:

Keywords:

基金项目(Foundation): 河北省2017年度医学科学研究重点课题(20170181)

作者(Author): 李建斌;刘新彦;李志强;王丽坤;路继成;李晓丽;
LI Jianbin;LIU Xinyan;LI Zhiqiang;WANG Likun;LU Jicheng;LI Xiaoli;Department of Otorhinolaryngology,Central Hospital of China National Petroleum Corporation;Department of Otorhinolaryngology-Head and Neck Surgery,the Second Affiliated Hospital,Hebei North University;Department of Pathology,the Second Affiliated Hospital of Hebei North University;Department of Clinical Laboratory,Xuanhua District People's Hospital;

Email:

DOI: 10.19367/j.cnki.1000-2707.2018.07.012

参考文献(References)：

• [1]MOLLENHAUER J,WIEMANN S,SCHEURLEN W,et al.DMBT1,a new member of the SRCR superfamily,on chromosome 10q25.3-26.1 is deleted in malignant brain tumors[J].Nat Genet,1997,17(1):32-39.
• [2]DENG H,GAO Y B,WANG H F,et al.Expression of deletedin malignant brain tumours 1(DMBT1)relates to the proliferationproliferationand malignant transformation of hepatic progenitorcells in hepatitis B virus-related liver diseases[J].Histopathology,2012,60(2):249-260.
• [3]罗文彦,左连富,成媛,等.食管鳞状细胞癌中DMBT1和CD44v6的表达及意义[J].河北医药,2015,37(9):1290-1292.
• [4]DODURGA Y,AVCI C B,YILMAZ S,et al.Evaluation of deletedin malignant brain tumors 1(DMBT1)gene expression inbladder carcinoma cases:Preliminary study[J].Biomarkers,2011,16(7):610-615.
• [5]王瑞海,崔大为,翟宏芳.DMBT1在乳腺癌组织中的表达及临床意义.肿瘤学杂志[J],2014,20(2):102-105.
• [6]黄素宁,王仁生,梁菲菲,等.局部晚期鼻咽癌诱导化疗联合同期放化疗的临床观察[J].中华肿瘤防治杂志,2013,20(8):614-617.
• [7]吴金通,彭俊英,吴陈宾,等.三维适形调强放疗同步顺铂化疗尼妥珠单抗治疗局部晚期鼻咽癌的临床疗效[J].中国癌症防治杂志,2014,6(1):47-51.
• [8]谢源福,林坤花,卓延红,等.诱导化疗加同步放化疗治疗局部晚期鼻咽癌的疗效观察[J].中国肿瘤临床与康复,2014,21(2):198-201.
• [9]江晓聪.放疗联合分子靶向药物治疗鼻咽癌的临床效果观察[J].白求恩医学杂志,2015,13(1):47-49.
• [10]RIDNOUR L A,CHENG R Y,SWITZER C H,et al.Molecular pathways:Toll-like receptors in the tumor microenvironment poor prognosis or new therapeutic opportunity[J].Clin Cancer Res,2013,19(6):1340-1346.
• [11]鄢践,焦艳.鼻咽癌分子生物学研究进展.肿瘤防治研究[J],2001,28(1):63-66.
• [12]SMITH H A,KANG Y.The metastasis-promoting roles of tumor-associated immune cells[J].J Mol Med(Berl),2013,91(4):411-429.
• [13]BIKKER F J,VANDERWAL J E,LIGTENBERG A J,et al.Salivary agglutinin/DMBT1SAG expression is up regulated in the presence of salivary glandtumors[J].J Dent Res,2004,83(7):567-571.
• [14]MOLLENHAUER J,HERBERTZ S,HOLMSKOV U,et al.DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer[J].Cancer Res,2000,60(6):1704-1710.
• [15]向少龙,刘娟娟,赵艳,等.靶向沉默HIF-1α和Survivin基因对鼻咽癌裸鼠移植瘤放疗敏感性的影响[J].贵州医科大学学报,2017,42(4):377-382,388.

文章评论(Comment)：